title: Is symptomatic treatment an option for a boy with clinically significant psychotic-like experiences and depressed mood? Comment on Ruhrmann et al., "intervention in at-risk states for developing psychosis." (Eur Arch Psychiatry Clin Neurosci 260 Suppl 2:S90-94).
authors: Hsiang-Yuan
authors: HY
authors: Lin
authors: Yen-Nan
authors: YN
authors: Chiu
authors: Chen-Chung
authors: CC
authors: Liu
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use*; D006801:Humans; D001523:Mental Disorders / Q000628:therapy*; D011613:Psychotherapy / Q000379:methods*
chemical_list: D014150:Antipsychotic Agents; D015525:Fatty Acids, Omega-3